HUM vs ORMP
Humana Inc (HUM) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the HUM and ORMP stock pages for the full models.
Not investment advice.